Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Dana R. Stewart, First Executive Vice President and Chief Operating Officer of Mid Penn Bank, notified the company of his resignation effective October 30, 2026. The company stated the departure was not due to any disagreement regarding operations, policies, or practices.
Eric Affeldt resigned from the Board of Directors of AIAI Holdings Corporation, effective October 21, 2026. The company stated the resignation was not due to any dispute or disagreement regarding operations, policies, or practices.
Albert G. White III has resigned as President, CEO, and Director of CooperCompanies, effective immediately, and will serve as a strategic advisor through April 1, 2027. The Board appointed independent director Walter M. Rosebrough, Jr. as interim Executive Chair to oversee operations while a search for a permanent CEO is conducted. Additionally, the company announced the appointment of Shlomo Nachman to the Board and the planned retirement of three other directors at the 2027 Annual Meeting.
David Swan has resigned from his positions as Chief Commercial Officer and a member of the Board of Directors of Sumisho Air Lease Corporation, effective October 27, 2026. The company stated that his departure was not due to any disagreement regarding operations, policies, or practices.
Jude Bricker resigned from the Board of Directors of Allegiant Travel Company effective October 23, 2026. The resignation was submitted due to a change in personal circumstances involving his role as owner and CEO of a newly formed company acquiring a U.S. charter airline.
George S. Pearce retired from the Board of Directors of CSB Financial Inc. and its subsidiary, Community Savings Bank, effective October 23, 2026. Richard E. Dyer was elected to fill the vacancy and will serve as the Chair of the Audit Committee. The company also amended its bylaws to remove a residency requirement for directors.
Ares Sports, Media & Entertainment Opportunities Leadership Change
Paul Cho is stepping down as Co-Chief Accounting Officer of Ares Sports, Media & Entertainment Opportunities LP effective October 31, 2026, to continue in a different role at Ares Management Corporation. Kimberly Zaccagnino, previously Co-CAO, has been appointed as the sole Chief Accounting Officer and Principal Accounting Officer, while Scott C. Lem will transition out of the Principal Accounting Officer role but remain CFO and Treasurer.
Visteon Corporation announced that Jerome J. Rouquet will step down as CFO effective November 30, 2026, to pursue other opportunities. Colleen E. Myers, the company's current Chief Accounting Officer, has been appointed interim CFO while the board conducts a search for a permanent successor.
Paul Cho is stepping down as Chief Accounting Officer and Principal Accounting Officer of Ares Strategic Income Fund, effective October 31, 2026. Scott Lem, the Fund's current CFO and Treasurer, will assume the additional role of Principal Accounting Officer. The departure was not due to any disagreement with the Fund's operations or policies.
International Battery Metals Ltd. appointed Donald E. Bender as Interim Chief Executive Officer, effective October 26, 2026, succeeding James Garrett Galloway. Mr. Bender, who also serves as VP of Technology & Engineering, will receive an additional annualized cash compensation of $100,000 for the interim role, while Mr. Galloway returns to his position as SVP of Corporate Development.
Hasbro, Inc. has appointed Dan Ayoub as President of Wizards of the Coast and Hasbro Digital Games, effective November 2, 2026. Ayoub, a 25-year industry veteran and former Microsoft executive, was promoted from his current role as Senior Vice President of Dungeons & Dragons. He will lead major franchises including Magic: The Gathering and Dungeons & Dragons across both tabletop and digital platforms.
Torran Nixon will transition from his role as Co-President of Columbia Bank and Senior EVP of the Company on July 1, 2027. He will then serve in a senior advisor role through his retirement on December 31, 2027, maintaining his salary and eligibility for 2027 equity grants and prorated incentive payouts.
Jorge L. Verar resigned as Chief Financial Officer of TV Channels Network, Inc., effective October 31, 2026. In response, the Board designated current CEO, President, and Chairman Darryl Payne to take on the additional roles of principal financial officer and principal accounting officer.
Merlin, Inc. has appointed Mark Brunner as President, effective October 27, 2026. Mr. Brunner, who previously served as the company's Chief Revenue Officer, succeeds Matthew George in the role of President, while Mr. George continues to serve as CEO and Chairman of the Board.
BlackBerry Limited has appointed David Chaikof, a legal veteran and investment executive, to its Board of Directors as an independent director. Mr. Chaikof previously served as external counsel to the company for over a decade and currently serves as a Senior Strategic Advisor at Osmington Inc. His appointment increases the board size to nine directors, eight of whom are independent.
Altimmune appointed Peter Greenleaf and Alex Howarth to its Board of Directors effective November 2, 2026, increasing the board size to eleven. As part of a planned transition, directors John M. Gill, Mitchel Sayare, and Klaus O. Schafer will retire at the 2027 Annual Meeting. The new directors will receive an annual cash retainer of $40,000 and initial stock options for 160,000 shares each.
Entera Bio Ltd. appointed Dr. Juan Camilo Arjona Ferreira, currently the CMO of Organon & Co., as a Class II director effective December 1, 2026. Simultaneously, Haya Taitel notified the board of her resignation as a director, also effective December 1, 2026. Dr. Arjona Ferreira will participate in the company's standard non-employee director compensation program.
Faeth Therapeutics increased its board size from six to seven and appointed Adam Schayowitz, Ph.D., as a Class III director. Dr. Schayowitz, currently EVP and Head of R&D at Zymeworks, brings extensive oncology drug development experience from previous roles at Pfizer and Tesaro. He will receive a standard non-employee director compensation package, including an initial option to purchase 25,000 shares of common stock.
First Horizon Corporation elected Dr. Jeffrey R. Balser to its Board of Directors, effective October 26, 2026. Dr. Balser, who serves as the President and CEO of Vanderbilt University Medical Center, will join the Nominating and Corporate Governance and Information Technology Committees.
Better Home & Finance Holding Company appointed Linda Yaccarino, CEO of eMed and former CEO of X Corp, to its Board of Directors as an independent director. Additionally, Paula Tuffin resigned from the Board effective immediately, though she will continue in her executive roles as General Counsel, Chief Compliance Officer, and Secretary.
Amgen Inc. has appointed David W. Gibbs, the former CEO of Yum! Brands, to its Board of Directors, effective immediately. Mr. Gibbs will serve on the Audit and Compensation committees, bringing the total board size to 13 directors. He will receive the company's standard non-employee director compensation, including a pro-rated annual cash retainer and restricted stock units.
Green Brick Partners appointed its Co-Chief Executive Officer, Jed Dolson, to the Board of Directors, effective October 22, 2026. Concurrently with his appointment, the Board was expanded from six to seven directors. Mr. Dolson will serve a term expiring at the 2027 Annual Meeting of Stockholders.
Cycurion, Inc. appointed J. Derek Penn to its Board of Directors and its Audit, Compensation, and Nominating committees, effective October 20, 2026. Simultaneously, Peter R. Ginsberg stepped down from all board committees after it was determined he no longer met independence requirements due to his role as outside legal counsel, though he remains a director.
Par Chadha, Chairman of the Board of Directors, notified XBP Global Holdings that he will not stand for re-election at the company's next annual meeting of stockholders. Mr. Chadha will continue to serve as Chairman until the expiration of his current term, and his departure is not due to any disagreement with the company.
Standex International Corporation appointed Brenna D. Preisser as a Class I director, effective January 1, 2027, succeeding the retiring B. Joanne Edwards. Ms. Preisser, currently an Executive Vice President at Brunswick Corporation, will receive a $150,000 restricted stock award and standard non-employee director compensation.
Soren Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Jamie Weber. Additionally, Roger Cloutier Jr. and Austin Criden were appointed to the board following the resignations of Spencer Gerrol and Charles N. Kahn III. These changes are part of a broader alignment with the Di Rezze Family Office, which sponsors the SPAC.
Praetorian Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Peter Ondishin. The company also appointed Roger L. Cloutier, Jimmy Vaiopoulos, and Charles P. Garcia to its board of directors following the resignations of Nicole Seligman, Erica Dorfman, and Alex Elias.
TrueBlue, Inc. has appointed Elizabeth Castro Gulacsy to its Board of Directors and its Audit Committee, effective October 26, 2026. Ms. Castro Gulacsy, the former CFO of United Parks & Resorts, joins as an independent director as part of a board refreshment process and a previously disclosed cooperation agreement with EHS Management. Her appointment increases the total number of directors on the TrueBlue board to ten.
OpenWorld, Inc. appointed Gerard Hernandez as Chief Financial Officer, effective October 23, 2026, succeeding Jennifer Cola who was removed from the role. Hernandez previously served as the company's Chief Accounting Officer and is a co-founder of the OpenWorld business.
Marella Thorell, Executive Vice President and Chief Financial Officer of Seres Therapeutics, Inc., resigned from her positions effective November 15, 2026. She is expected to provide advisory services to the company following her departure to support an orderly transition.